Transcriptome Assessment After Cardiac Arrest
OMECARD
" Etude du Transcriptome Complet Lors du Syndrome Post-arrêt Cardiaque " Transcriptome Assessment After Cardiac Arrest
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to determine whether the blood transcriptome of patients resuscitated after out-of-hospital could be an early predictor of the neurological outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2019
CompletedFirst Posted
Study publicly available on registry
March 29, 2019
CompletedStudy Start
First participant enrolled
February 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2022
CompletedNovember 20, 2025
October 1, 2025
2 years
March 21, 2019
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Early Transcriptome at hospital admission
Blood samples will be collected for each patient early after admission at hospital and blood whole transcriptome will be assessed by RNA sequencing
Day 0
Pittsburgh Cerebral Performance Category at Day 60
Pittsburgh Cerebral Performance Category will be evaluated for each patient at day 60
Day 60
Secondary Outcomes (5)
Transcriptome at day 1
Day 1
Transcriptome at day 3
Day 3
Pittsburgh Cerebral Performance Category at Day 28
day 28
Number of participants with death at day 28
day 28
Number of participants with death at day 60
day 60
Interventions
Sampling of 15 ml of blood during a blood test at Day 0, Day 1 and Day 3
Eligibility Criteria
You may qualify if:
- Age between 18 and 80 years
- Delay between patients collapse and resumption of spontaneous circulation (ROSC) \< 60 minutes
- Comatose patients ROSC with Glasgow score \< 7
- Patient already registered in the social security system
- Consent of a family member, if able to understand in the emergency context, or attestation of emergency situation with a follow-up information notice
You may not qualify if:
- Cardiac arrest supposed to be provoked by trauma or sepsis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assistance Publique - Hôpitaux de Parislead
- National Research Agency, Francecollaborator
- University of Paris 5 - Rene Descartescollaborator
- Institut National de la Santé Et de la Recherche Médicale, Francecollaborator
- Paris 12 Val de Marne Universitycollaborator
- Ecole Nationale Vétérinaire d'Alfortcollaborator
- URC-CIC Paris Descartes Necker Cochincollaborator
Study Sites (1)
Hôpital Cochin, Assistance Publique Hôpitaux de Paris
Paris, 75005, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alain Cariou, Prof.
Assistance Publique - Hôpitaux de Paris
- STUDY CHAIR
Renaud Tissier, Prof
Ecole Nationale Vétérinaire d'Alfort
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2019
First Posted
March 29, 2019
Study Start
February 24, 2020
Primary Completion
February 10, 2022
Study Completion
February 10, 2022
Last Updated
November 20, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share